NEWS
Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development
Champions Oncology (CSBR) announced a strategic collaboration with Medicines Discovery Catapult (MDC) to boost the development of radiopharmaceutical therapeutics. This partnership leverages Champions' patient-derived models and pharmacology solutions with MDC's radiochemistry and multi-modal imaging expertise. The collaboration aims to advance radionuclide therapies, offering new hope for cancer patients. This synergy addresses the need for combined specialized expertise and clinically relevant models in radioligand therapies, positioning both organizations to drive significant advancements in the field.
Champions Oncology (CSBR) announced a strategic collaboration with Medicines Discovery Catapult (MDC) to boost the development of radiopharmaceutical therapeutics. This partnership leverages Champions' patient-derived models and pharmacology solutions with MDC's radiochemistry and multi-modal imaging expertise. The collaboration aims to advance radionuclide therapies, offering new hope for cancer patients. This synergy addresses the need for combined specialized expertise and clinically relevant models in radioligand therapies, positioning both organizations to drive significant advancements in the field.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Spread kindness and love. Life is short. Don’t let greed eat you.
2702Followers
108Following
29KVisitors
Follow